Soluble interleukin-2 receptor and soluble CD8 in liver cirrhosis and obstructive jaundice (Q43745794)

26 November 2017

title

Soluble interleukin-2 receptor and soluble CD8 in liver cirrhosis and obstructive jaundice (English)

1 reference

26 November 2017

1 reference

Wagner F

1

1 reference

26 November 2017

Assemi C

2

1 reference

26 November 2017

Lersch C

3

1 reference

26 November 2017

Hart R

4

1 reference

26 November 2017

Classen M

5

1 reference

26 November 2017

publication date

1 November 1990

1 reference

Clinical and Experimental Immunology

26 November 2017

published in

1 reference

26 November 2017

volume

82

1 reference

26 November 2017

issue

2

1 reference

26 November 2017

page(s)

344-349

1 reference

Immune status in mice with experimental biliary obstruction.

26 November 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1535106

Prediction of risk in biliary surgery

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1535106

Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1535106

A FORTRAN program to perform the nonparametric Terpstra-Jonckheere test.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1535106

Transection of the oesophagus for bleeding oesophageal varices

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1535106

Immunoglobulins in chronic liver disease

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1535106

Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1535106

Impaired specific cell-mediated immunity in experimental biliary obstruction and its reversibility by internal biliary drainage

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1535106

Impaired immune function in obstructive jaundice

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1535106

Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1535106

The malignant B cells from B-chronic lymphocytic leukemia patients release TAC-soluble interleukin-2 receptors

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1535106

Soluble interleukin-2 receptors in systemic lupus erythematosus

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1535106

Soluble interleukin 2 receptors are released from the cell surface of normal murine B lymphocytes stimulated with interleukin 5.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1535106

The released interleukin 2 receptor binds interleukin 2 efficiently

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1535106

Soluble IL-2 receptor levels in serum from blood donors seropositive for HIV.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1535106

Increase of serum interleukin 2 receptor level in thermally injured patients

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1535106

Soluble CD8 during T cell activation

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1535106

Interleukins and the immune system 1.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1535106

Tumor necrosis factor alpha production by peripheral blood mononuclear cells of patients with chronic liver disease

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1535106

Molecular interactions, T-cell subsets and a role of the CD4/CD8:p56lck complex in human T-cell activation

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1535106

Serum levels of soluble interleukin-2 receptors in acute and chronic viral hepatitis

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1535106

Increased levels of soluble CD8 molecule in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1535106

Sepsis in the management of complicated biliary disorders

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1535106

T cells from patients with chronic liver diseases: abnormalities in PHA-induced expression of HLA class II antigens and in autologous mixed-lymphocyte reactions

29 September 2018

1 reference

12 December 2020

Plasma interleukin 2 receptor levels in renal allograft recipients

1 reference

12 December 2020

Decreased interleukin 1 activity in culture supernatant of lipopolysaccharide stimulated monocytes from patients with liver cirrhosis and hepatocellular carcinoma

1 reference

12 December 2020

Profound suppression of lymphocyte function in early biliary obstruction

1 reference

12 December 2020

Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseases

1 reference

12 December 2020

Soluble interleukin-2 receptors in serum and bile of liver transplant recipients

1 reference

12 December 2020

Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis

1 reference

12 December 2020

High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production

1 reference

12 December 2020

The half-life of I131 labeled normal human gamma globulin in patients with hepatic cirrhosis

1 reference

12 December 2020

Serum immunoglobulin concentrations in patients with alcoholic liver disease

1 reference

12 December 2020

Effect of biliary obstruction on skin allograft survival in mice

1 reference

12 December 2020

Inhibition of PHA-stimulated lymphocyte transformation by plasma from patients with advanced alcoholic cirrhosis

1 reference

12 December 2020

Lymphocyte transformation by phytohaemagglutinin (PHA) and purified protein derivative (PPD) in primary biliary cirrhosis. Evidence of serum inhibitory factors

1 reference

12 December 2020

In vitro and in vivo studies of cellular immunity in alcoholic cirrhosis

1 reference

12 December 2020

Liver disease--a prominent cause of serum IgE elevation

1 reference

12 December 2020

Peripheral blood lymphocyte populations in chronic liver disease

1 reference

12 December 2020

Serum immunoglobulins and organ non-specific antibodies in diseases of the liver

1 reference

12 December 2020

Serum immunoglobulin A changes in alcoholic patients

1 reference

12 December 2020

Factors affecting mortality in biliary tract surgery

1 reference

12 December 2020

Biliary obstruction and host defense failure

1 reference

12 December 2020

Decreased natural killer activity in patients with liver cirrhosis

1 reference

12 December 2020

Surgical experience of deeply jaundiced patients with bile duct obstruction

1 reference

12 December 2020

Deficient natural killer cell activity in alcoholic cirrhosis

1 reference

12 December 2020

Interleukin 1 activity in culture supernatant of lipopolysaccharide-stimulated monocytes from patients with chronic liver disease

1 reference

12 December 2020

10.1111/J.1365-2249.1990.TB05450.X

Identifiers

DOI

1 reference

26 November 2017

0 references

1 reference